Search Press releases Keywords From To 9 Apr 2019 FDA Approves Evenity™ (Romosozumab) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture Read More 8 Apr 2019 Transparency notification BlackRock, Inc. Read More 4 Apr 2019 Acquisition of own shares Read More 2 Apr 2019 Transparency notifications BlackRock, Inc. Read More 31 Mar 2019 UCB to provide additional information to the US FDA regarding midazolam nasal spray submission Read More 29 Mar 2019 Transparency notification BlackRock, Inc. Read More Pagination First page Previous page Previous … Page 60 Page 61 Page 62 Page 63 Current page 64 Page 65 Page 66 Page 67 Page 68 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
